Showing results (211-220 of 642) with videos related to
Sort By:
Pageof 65
Journal of Heterocyclic Chemistry|February 10, 2006
Isomerization/Recyclization of some 5-Ethoxycarbonyl-pyrimidinesR S Vardanyan, V J Hruby, G G Danagulyan, et al.Biopolymers|July 9, 1999
Structure and dynamics of alpha-MSH using DRISM integral equation theory and stochastic dynamicsN V Prabhu, J S Perkyns, B M Pettitt, et al.Journal of Neurochemistry|March 1, 1996
Passage of a delta-opioid receptor selective enkephalin, [D-penicillamine2,5] enkephalin, across the blood-brain and the blood-cerebrospinal fluid barriersS A Williams, T J Abbruscato, V J Hruby, et al.International Journal of Peptide and Protein Research|September 1, 1995
A topographical model of mu-opioid and brain somatostatin receptor selective ligands. NMR and molecular dynamics studiesW M Kazmierski, R D Ferguson, A W Lipkowski, et al.The Journal of Pharmacology and Experimental Therapeutics|January 1, 1997
Blood-brain barrier permeability and bioavailability of a highly potent and mu-selective opioid receptor antagonist, CTAP: comparison with morphineT J Abbruscato, S A Thomas, V J Hruby, et al.The Journal of Peptide Research : Official Journal of the American Peptide Society|May 20, 2003
Effect of peptide conformation on membrane permeabilityV Boguslavsky, V J Hruby, D F O'Brien, et al.The Journal of Pharmacology and Experimental Therapeutics|October 19, 1999
High-affinity interaction of (des-Tyrosyl)dynorphin A(2-17) with NMDA receptorsQ Tang, R Gandhoke, A Burritt, et al.Journal of Medicinal Chemistry|November 1, 1986
Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptorsJ T Pelton, W Kazmierski, K Gulya, et al.The Journal of Biological Chemistry|November 15, 1987
Interactions of glucagon and glucagon analogs with isolated canine hepatocytesW A Hagopian, H S Tager, B Gysin, et al.The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligandsT H Kramer, P Davis, V J Hruby, et al.Pageof 65